Pitavastatin or bezafibrate intervention, assessment of antiarteriosclerotic effect (PIONEER).
Phase of Trial: Phase III
Latest Information Update: 22 May 2014
At a glance
- Drugs Pitavastatin (Primary) ; Bezafibrate
- Indications Atherosclerosis; Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms PIONEER
- 20 Nov 2013 Status changed from active, no longer recruiting to completed.
- 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 18 Nov 2013 Primary endpoint 'Intima-media-thickness' has been met.